President Donald Trump has stated that a nuclear technology agreement with Saudi Arabia will be contingent on the kingdom’s participation in the Abraham Accords. The Accords, initiated in 2020, are a U.S.-brokered framework aimed at normalizing relations between Israel and several Arab nations. Currently, Saudi Arabia has not joined the Accords, often linking normalization with Israel to advancements in Palestinian statehood. Trump’s condition introduces a significant diplomatic hurdle, as the U.S.-Saudi nuclear cooperation deal had already been approved, pending Riyadh’s engagement in the Accords. This development raises stakes both diplomatically and in terms of nuclear security, given the scrutiny over uranium enrichment and nonproliferation safeguards.

Key Takeaways

• Trump’s condition appears to increase uncertainty for the U.S.-Iran negotiations, suggesting a potential decrease in the likelihood of Iran Reconstruction Funding being included in a 2026 deal.
• Market pricing indicates a decrease in confidence for the U.S.-Iran deal’s success, with odds shifting from 30% to 28.5% for the inclusion of reconstruction funding.
• The linkage between Saudi participation in the Abraham Accords and the nuclear deal with the U.S. could complicate regional diplomatic relations and influence broader geopolitical dynamics.

What to Watch

Observe U.S. diplomatic efforts to persuade Saudi Arabia to join the Abraham Accords, as this could significantly impact the potential for a U.S.-Iran deal in 2026. Attention should also be paid to Iran’s response to these developments, as any shift in their stance could reflect in market adjustments. Further statements from Trump or Saudi officials could provide additional context on the likelihood of these diplomatic conditions being met.

Get live prediction-market analysis, powered by Vera. Sign up for Vera.